Glutamine in Critical Illness - PowerPoint PPT Presentation

1 / 15
About This Presentation
Title:

Glutamine in Critical Illness

Description:

Shiva Sharma SHO Breast/Endocrine Surgery Introduction Roles of Glutamine in the body Tissue Protection Anti-inflammatory regulation Preservation of metabolic ... – PowerPoint PPT presentation

Number of Views:228
Avg rating:3.0/5.0
Slides: 16
Provided by: ShivaS8
Category:

less

Transcript and Presenter's Notes

Title: Glutamine in Critical Illness


1
Glutamine in Critical Illness
  • Shiva Sharma
  • SHO Breast/Endocrine Surgery

2
Contents
  • Introduction
  • Roles of Glutamine in the body
  • Tissue Protection
  • Anti-inflammatory regulation
  • Preservation of metabolic function
  • Glutamine as therapy

3
  • Leading cause of death in critically ill patients
    is sepsis
  • 230,000 deaths in the USA each year secondary to
    sepsis
  • Mortality rate from sepsis risen by 90 in last
    20years
  • Development of multi-organ failure
  • Organ dysfunction secondary to shock,
    inflammation, metabolic disturbances

4
What is Glutamine?
  • Non-essential amino acid
  • Most abundant AA in the body
  • 50 free AA in plasma
  • Energy source
  • Precursor to glutathione
  • For nucleic acid synthesis
  • Anti-oxidant effects
  • Used for nitrogen transfer

5
Roles
  • Kidney
  • Acid-base regulation
  • Releases ammonia in urine
  • Combines with proton to release bicarbonate into
    renal venous bed
  • Immune response
  • Fuel for monocytes, macrophages, lymphocytes
  • Unable to synthesise, rely on plasma glutamine

6
Roles of Glutamine
7
Glutamine in Critical Illness
  • Over last 15-20 years effects of glutamine
    studied in ICU setting
  • Beneficial effects including decreased
    morbidity/mortality
  • Patients in ICU in profound catabolic states
  • Release of amino acids from muscle breakdown
  • Glutamine however does not increase in critically
    ill patients

8
  • Decrease in plasma glutamine observed in
    critically ill patients
  • Planas M, Schwartz S, Arbos MA, et al Plasma
    glutamine levels in septic patients. JPEN J
    Parenter Enteral Nutr 1993 17299300
  • Low glutamine has also been associated with
    increased mortality in ICU patients
  • Oudemans-van Straaten HM, et al Plasma glutamine
    depletion and patient outcome in acute ICU
    admissions. Intensive Care Med 2001 278490

9
Mechanism
  • Not fully understood
  • ?signalling molecule to regulate gene expression
    and intracellular signalling
  • Stress signal to the body increase cellular and
    immune defence

10
Tissue Protection
  • Enhancement of Heat Shock Proteins
  • These proteins are vital to cellular response to
    stresses, and regulate the management of
    intracellular proteins
  • Wischmeyer etal. performed a series of
    experiments in a rat model to show that glutamine
    enhanced HSP-70 in septic rats
  • Metabolic dysfunction was decreased
  • ARDS decreased
  • Decreased Mortality

11
  • Ziegler TR etal. also went on to perform a pilot
    study Double blind trial looking at Glutamine vs
    Isonitrogenous control solution in ICU patients
    on TPN for gt5days
  • Glutamine given as 0.5mg/kgday
  • Showed increase in HSP-70 expression
  • Decrease in ICU stay
  • Ziegler TR, Ogden LG, Singleton KD, et al
    Parenteral glutamine increases serum heat shock
    protein 70 in critically ill patients. Intensive
    Care Med 2005 3110791086

12
Anti-Inflammatory Regulation
  • Activates peroxisome proliferation activated
    receptor-DNA binding sites
  • This leads to attenuation of inflammatory
    response pathways through inhibitory
    transcription factors
  • Glutamines acts on NF-kB signalling pathways
  • ?HSP link, as HSP knockout mice loose this
    attenuation ability when glutamine administered
    after sepsis

13
Metabolic Function
  • Glutamine decreases insulin resistance
  • Reduced hyperglycaemia in ICU patients
  • Enhances release of insulin from Beta-cells
  • Overall improved insulin sensitivity after
    administration
  • Dechelotte P, et al L-alanyl-L-glutamine
    dipeptide-supplemented total parenteral nutrition
    reduces infectious complications and glucose
    intolerance in critically ill patients The
    French controlled, randomized, double-blind,
    multicenter study. Crit Care Med 2006 34598604

14
Glutamine as a Therapy
  • Multiple advantages described to support
    glutamine administration
  • Parenteral and enteral supplementation decrease
    mortality
  • REDOXS study looking at glutamines ability to
    protect against injury, reduce inflammation,
    preserve metabolic function

15
  • Critical Care Connections Inc 2005 (Canadian
    Clinical Practice Guidelines) suggest
    supplementation of parenteral nutrition with
    glutamine and enteral glutamine for burns/trauma
    patients
  • Possible role in patient nutrition
  • Possible role as prophylaxis in surgery/ICU for
    prolonged admissions
Write a Comment
User Comments (0)
About PowerShow.com